MENU
Pancreatic Cancer Research
Pancreatic cancer is the third leading cause of cancer-related death in the United States, for men and women
In a single year, more than 57,000 Americans will be diagnosed with the disease, and more than 47,000 will die from it. Without an effective screening method for pancreatic cancer, diagnosis often comes late when the cancer has advanced into a stage where surgery is not an option. Once this cancer spreads throughout the body -- which it is quick to do -- patients must rely on chemotherapy.
Rogel Cancer Center researchers are at the forefront of research on pancreatic cancer
Led by a multidisciplinary team of scientists and clinicians, our research program holds the promise to significantly change the dismal statistics associated with this disease by revolutionizing pancreatic cancer care. With a uniquely collaborative approach, the team is attacking the disease on a variety of fronts.